Selected research
Industry Growth & Trends
Global Oxycodone Hydrochloride Injection Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global Oxycodone Hydrochloride Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Oxycodone Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Oxycodone Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Oxycodone Hydrochloride Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the Oxycodone Hydrochloride Injection market include LTL Pharma Co., Ltd., NAPP PHARMACEUTICALS LIMITED, Organon LLC, Sumitomo Pharma America, Inc., Teva Takeda Yakuhin Ltd., Santen Pharmaceutical Co.,Ltd., Hengrui Medicine, Mylan Pharmaceuticals and Teva Pharmaceutical Industries, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Oxycodone Hydrochloride Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Oxycodone Hydrochloride Injection market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oxycodone Hydrochloride Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oxycodone Hydrochloride Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global Oxycodone Hydrochloride Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Oxycodone Hydrochloride Injection Market by Company
LTL Pharma Co., Ltd.
NAPP PHARMACEUTICALS LIMITED
Organon LLC
Sumitomo Pharma America, Inc.
Teva Takeda Yakuhin Ltd.
Santen Pharmaceutical Co.,Ltd.
Hengrui Medicine
Mylan Pharmaceuticals
Teva Pharmaceutical Industries
Oxycodone Hydrochloride Injection Segment by Type
2ml:20mg
1ml:10mg
Oxycodone Hydrochloride Injection Segment by Application
Hospital
Clinic
Others
Oxycodone Hydrochloride Injection Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Hydrochloride Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Hydrochloride Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Hydrochloride Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of Oxycodone Hydrochloride Injection companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- 2ml:20mg
- 1ml:10mg
Applications
- Hospital
- Clinic
- Others
Companies covered
- LTL Pharma Co., Ltd.
- NAPP PHARMACEUTICALS LIMITED
- Organon LLC
- Sumitomo Pharma America, Inc.
- Teva Takeda Yakuhin Ltd.
- Santen Pharmaceutical Co.,Ltd.
- Hengrui Medicine
- Mylan Pharmaceuticals
- Teva Pharmaceutical Industries
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global Oxycodone Hydrochloride Injection Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global Oxycodone Hydrochloride Injection Market Size by Region (2021-2032)
- 1.4.1 Global Oxycodone Hydrochloride Injection Market Size by Region (2021-2026)
- 1.4.2 Global Oxycodone Hydrochloride Injection Market Size by Region (2027-2032)
- 1.5 Key Regions Oxycodone Hydrochloride Injection Market Size (2021-2032)
- 1.5.1 North America Oxycodone Hydrochloride Injection Market Size Growth Rate (2021-2032)
- 1.5.2 Europe Oxycodone Hydrochloride Injection Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific Oxycodone Hydrochloride Injection Market Size Growth Rate (2021-2032)
- 1.5.4 South America Oxycodone Hydrochloride Injection Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa Oxycodone Hydrochloride Injection Market Size Growth Rate (2021-2032)
2 Oxycodone Hydrochloride Injection Market by Type
- 2.1 Type Introduction
- 2.1.1 2ml:20mg
- 2.1.2 1ml:10mg
- 2.2 Global Oxycodone Hydrochloride Injection Market Size by Type
- 2.2.1 Global Oxycodone Hydrochloride Injection Market Size Overview by Type (2021-2032)
- 2.2.2 Global Oxycodone Hydrochloride Injection Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global Oxycodone Hydrochloride Injection Market Size Forecasted by Type (2027-2032)
- 2.3 Global Oxycodone Hydrochloride Injection Market Size by Regions
- 2.3.1 North America Oxycodone Hydrochloride Injection Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe Oxycodone Hydrochloride Injection Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific Oxycodone Hydrochloride Injection Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America Oxycodone Hydrochloride Injection Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa Oxycodone Hydrochloride Injection Market Size Breakdown by Type (2021-2026)
3 Oxycodone Hydrochloride Injection Market by Application
- 3.1 Type Introduction
- 3.1.1 Hospital
- 3.1.2 Clinic
- 3.1.3 Others
- 3.2 Global Oxycodone Hydrochloride Injection Market Size by Application
- 3.2.1 Global Oxycodone Hydrochloride Injection Market Size Overview by Application (2021-2032)
- 3.2.2 Global Oxycodone Hydrochloride Injection Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global Oxycodone Hydrochloride Injection Market Size Forecasted by Application (2027-2032)
- 3.3 Global Oxycodone Hydrochloride Injection Market Size by Regions
- 3.3.1 North America Oxycodone Hydrochloride Injection Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe Oxycodone Hydrochloride Injection Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific Oxycodone Hydrochloride Injection Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America Oxycodone Hydrochloride Injection Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa Oxycodone Hydrochloride Injection Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 Oxycodone Hydrochloride Injection Industry Trends
- 4.2 Oxycodone Hydrochloride Injection Industry Drivers
- 4.3 Oxycodone Hydrochloride Injection Industry Opportunities and Challenges
- 4.4 Oxycodone Hydrochloride Injection Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by Oxycodone Hydrochloride Injection Revenue (2021-2026)
- 5.2 Global Oxycodone Hydrochloride Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global Oxycodone Hydrochloride Injection Key Company Headquarters & Area Served
- 5.4 Global Oxycodone Hydrochloride Injection Company, Product Type & Application
- 5.5 Global Oxycodone Hydrochloride Injection Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global Oxycodone Hydrochloride Injection Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 Oxycodone Hydrochloride Injection Players Market Share by Revenue in 2025
- 5.6.3 2025 Oxycodone Hydrochloride Injection Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 LTL Pharma Co., Ltd.
- 6.1.1 LTL Pharma Co., Ltd. Company Information
- 6.1.2 LTL Pharma Co., Ltd. Business Overview
- 6.1.3 LTL Pharma Co., Ltd. Oxycodone Hydrochloride Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 LTL Pharma Co., Ltd. Oxycodone Hydrochloride Injection Product Portfolio
- 6.1.5 LTL Pharma Co., Ltd. Recent Developments
- 6.2 NAPP PHARMACEUTICALS LIMITED
- 6.2.1 NAPP PHARMACEUTICALS LIMITED Company Information
- 6.2.2 NAPP PHARMACEUTICALS LIMITED Business Overview
- 6.2.3 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 NAPP PHARMACEUTICALS LIMITED Oxycodone Hydrochloride Injection Product Portfolio
- 6.2.5 NAPP PHARMACEUTICALS LIMITED Recent Developments
- 6.3 Organon LLC
- 6.3.1 Organon LLC Company Information
- 6.3.2 Organon LLC Business Overview
- 6.3.3 Organon LLC Oxycodone Hydrochloride Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Organon LLC Oxycodone Hydrochloride Injection Product Portfolio
- 6.3.5 Organon LLC Recent Developments
- 6.4 Sumitomo Pharma America, Inc.
- 6.4.1 Sumitomo Pharma America, Inc. Company Information
- 6.4.2 Sumitomo Pharma America, Inc. Business Overview
- 6.4.3 Sumitomo Pharma America, Inc. Oxycodone Hydrochloride Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 Sumitomo Pharma America, Inc. Oxycodone Hydrochloride Injection Product Portfolio
- 6.4.5 Sumitomo Pharma America, Inc. Recent Developments
- 6.5 Teva Takeda Yakuhin Ltd.
- 6.5.1 Teva Takeda Yakuhin Ltd. Company Information
- 6.5.2 Teva Takeda Yakuhin Ltd. Business Overview
- 6.5.3 Teva Takeda Yakuhin Ltd. Oxycodone Hydrochloride Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 Teva Takeda Yakuhin Ltd. Oxycodone Hydrochloride Injection Product Portfolio
- 6.5.5 Teva Takeda Yakuhin Ltd. Recent Developments
- 6.6 Santen Pharmaceutical Co.,Ltd.
- 6.6.1 Santen Pharmaceutical Co.,Ltd. Company Information
- 6.6.2 Santen Pharmaceutical Co.,Ltd. Business Overview
- 6.6.3 Santen Pharmaceutical Co.,Ltd. Oxycodone Hydrochloride Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Santen Pharmaceutical Co.,Ltd. Oxycodone Hydrochloride Injection Product Portfolio
- 6.6.5 Santen Pharmaceutical Co.,Ltd. Recent Developments
- 6.7 Hengrui Medicine
- 6.7.1 Hengrui Medicine Company Information
- 6.7.2 Hengrui Medicine Business Overview
- 6.7.3 Hengrui Medicine Oxycodone Hydrochloride Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.7.4 Hengrui Medicine Oxycodone Hydrochloride Injection Product Portfolio
- 6.7.5 Hengrui Medicine Recent Developments
- 6.8 Mylan Pharmaceuticals
- 6.8.1 Mylan Pharmaceuticals Company Information
- 6.8.2 Mylan Pharmaceuticals Business Overview
- 6.8.3 Mylan Pharmaceuticals Oxycodone Hydrochloride Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.8.4 Mylan Pharmaceuticals Oxycodone Hydrochloride Injection Product Portfolio
- 6.8.5 Mylan Pharmaceuticals Recent Developments
- 6.9 Teva Pharmaceutical Industries
- 6.9.1 Teva Pharmaceutical Industries Company Information
- 6.9.2 Teva Pharmaceutical Industries Business Overview
- 6.9.3 Teva Pharmaceutical Industries Oxycodone Hydrochloride Injection Revenue, Global Share and Gross Margin (2021-2026)
- 6.9.4 Teva Pharmaceutical Industries Oxycodone Hydrochloride Injection Product Portfolio
- 6.9.5 Teva Pharmaceutical Industries Recent Developments
7 North America
- 7.1 North America Oxycodone Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America Oxycodone Hydrochloride Injection Market Size by Country (2021-2026)
- 7.3 North America Oxycodone Hydrochloride Injection Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe Oxycodone Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe Oxycodone Hydrochloride Injection Market Size by Country (2021-2026)
- 8.3 Europe Oxycodone Hydrochloride Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Oxycodone Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific Oxycodone Hydrochloride Injection Market Size by Country (2021-2026)
- 9.3 Asia-Pacific Oxycodone Hydrochloride Injection Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America Oxycodone Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America Oxycodone Hydrochloride Injection Market Size by Country (2021-2026)
- 10.3 South America Oxycodone Hydrochloride Injection Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Oxycodone Hydrochloride Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa Oxycodone Hydrochloride Injection Market Size by Country (2021-2026)
- 11.3 Middle East & Africa Oxycodone Hydrochloride Injection Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst